Citation Impact
Citing Papers
Signal transduction to hypoxia-inducible factor 1
2002 StandoutNobel
Role of insulin-like growth factor 1 receptor signalling in cancer
2005
Analysis of Hypoxia‐Inducible Factor 1α Expression and its Effects on Invasion and Metastasis
2007 StandoutNobel
Brain metastases
2003
Functional responses and in vivo anti-tumour activity of h7C10: A humanised monoclonal antibody with neutralising activity against the insulin-like growth factor-1 (IGF-1) receptor and insulin/IGF-1 hybrid receptors
2007
Enhanced T-Cell Responses to Glioma Cells Coated With the Anti-EGF Receptor Antibody and Targeted to Activating FcγRs on Human Dendritic Cells
2008 StandoutNobel
A novel triple-modality reporter gene for whole-body fluorescent, bioluminescent, and nuclear noninvasive imaging
2004
Genes that mediate breast cancer metastasis to the brain
2009 StandoutNature
Gene Therapy-Mediated Reprogramming Tumor Infiltrating T Cells Using IL-2 and Inhibiting NF-κB Signaling Improves the Efficacy of Immunotherapy in a Brain Cancer Model
2012 StandoutNobel
Chemotherapy for malignant gliomas
1988
Targeting HIF-1 for cancer therapy
2003 StandoutNobel
Interleukin-13 Receptor-Directed Cytotoxin for Malignant Glioma Therapy: From Bench to Bedside
2003
HIF-1 and tumor progression: pathophysiology and therapeutics
2002 StandoutNobel
HIF-1: Using Two Hands to Flip the Angiogenic Switch
2000 StandoutNobel
Role of platelet-derived growth factors in physiology and medicine
2008 Standout
Spermidine/Spermine-N1-Acetyltransferase 2 Is an Essential Component of the Ubiquitin Ligase Complex That Regulates Hypoxia-inducible Factor 1α
2007 StandoutNobel
Heterozygous HIF‐1α deficiency impairs carotid body‐mediated systemic responses and reactive oxygen species generation in mice exposed to intermittent hypoxia
2006 StandoutNobel
Organometallic chemistry, biology and medicine: ruthenium arene anticancer complexes
2005 Standout
Molecular neuro-oncology and development of targeted therapeutic strategies for brain tumors. Part 1: growth factor and Ras signaling pathways
2003
Expression of Vascular Endothelial Growth Factor Receptor 1 in Bone Marrow-derived Mesenchymal Cells Is Dependent on Hypoxia-inducible Factor 1
2006 StandoutNobel
HIF-1 Inhibits Mitochondrial Biogenesis and Cellular Respiration in VHL-Deficient Renal Cell Carcinoma by Repression of C-MYC Activity
2007 StandoutNobel
Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma
2014 Standout
Insulin-like Growth Factor 1 Induces Hypoxia-inducible Factor 1-mediated Vascular Endothelial Growth Factor Expression, Which is Dependent on MAP Kinase and Phosphatidylinositol 3-Kinase Signaling in Colon Cancer Cells
2002 StandoutNobel
Insulin and insulin-like growth factor signalling in neoplasia
2008 Standout
Relation of Left Ventricular Mass and Geometry to Morbidity and Mortality in Uncomplicated Essential Hypertension
1991 Standout
Antisense and siRNA as agonists of Toll-like receptors
2004
Role of Hypoxia-Inducible Factor 1 in Gastric Cancer Cell Growth, Angiogenesis, and Vessel Maturation
2004 StandoutNobel
Regulation of Hypoxia-Inducible Factor-1α, Vascular Endothelial Growth Factor, and Angiogenesis by an Insulin-Like Growth Factor-I Receptor Autocrine Loop in Human Pancreatic Cancer
2003 StandoutNobel
Levels of Hypoxia-Inducible Factor-1 During Breast Carcinogenesis
2001 StandoutNobel
OS-9 Interacts with Hypoxia-Inducible Factor 1α and Prolyl Hydroxylases to Promote Oxygen-Dependent Degradation of HIF-1α
2005 StandoutNobel
Gut microbiota modulation of chemotherapy efficacy and toxicity
2017 Standout
Current state of immunotherapy for glioblastoma
2018
Gene Therapy for Malignant Glioma: Current Clinical Status
2005
CSF-1R inhibition alters macrophage polarization and blocks glioma progression
2013 Standout
Malignant Gliomas in Adults
2008 Standout
Dynamic regulation of stem cell specification and maintenance by hypoxia-inducible factors
2015 StandoutNobel
Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology
2001 StandoutNobel
Inhibiting kinases in malignant gliomas
2007
Hypoxia-Inducible Factor 1: Control of Oxygen Homeostasis in Health and Disease
2001 StandoutNobel
Targeting metabolism with a ketogenic diet during the treatment of glioblastoma multiforme
2014
Tumor metastasis: mechanistic insights and clinical challenges
2006 Standout
Immunotherapy of Diffuse Gliomas: Biological Background, Current Status and Future Developments
2009 Standout
β-Arrestin and Mdm2 Mediate IGF-1 Receptor-stimulated ERK Activation and Cell Cycle Progression
2007 StandoutNobel
Genes that mediate breast cancer metastasis to lung
2005 StandoutNature
Development of novel therapeutic strategies that target HIF-1
2006 StandoutNobel
FIH-1: a novel protein that interacts with HIF-1α and VHL to mediate repression of HIF-1 transcriptional activity
2001 StandoutNobel
Overview of Cellular Immunotherapy for Patients with Glioblastoma
2010
Insulin-Like Growth Factor-1 Inscribes a Gene Expression Profile for Angiogenic Factors and Cancer Progression in Breast Epithelial Cells
2002
Evaluation of HIF-1 inhibitors as anticancer agents
2007 StandoutNobel
Inhibition of IGF-I receptor in anchorage-independence attenuates GSK-3β constitutive phosphorylation and compromises growth and survival of medulloblastoma cell lines
2006
Spermidine/Spermine N1-Acetyltransferase-1 Binds to Hypoxia-inducible Factor-1α (HIF-1α) and RACK1 and Promotes Ubiquitination and Degradation of HIF-1α
2007 StandoutNobel
Management of glioblastoma: State of the art and future directions
2020 Standout
Multifaceted end points in brain tumor clinical trials: Cognitivedeterioration precedes MRI progression
2003
Hypoxia, Clonal Selection, and the Role of HIF-1 in Tumor Progression
2000 StandoutNobel
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
External imaging of CCND1 cancer gene activity in experimental human breast cancer xenografts with 99mTc-peptide-peptide nucleic acid-peptide chimeras.
2004
HER2 (neu) Signaling Increases the Rate of Hypoxia-Inducible Factor 1α (HIF-1α) Synthesis: Novel Mechanism for HIF-1-Mediated Vascular Endothelial Growth Factor Expression
2001 StandoutNobel
Glioblastoma Patients Exhibit Circulating Tumor-Specific CD8+ T Cells
2005
Regulation of apoptosis by the circadian clock through NF-κB signaling
2011 StandoutNobel
Stromal Cell–Derived Factor-1α and CXCR4 Expression in Hemangioblastoma and Clear Cell-Renal Cell Carcinoma: von Hippel-Lindau Loss-of-Function Induces Expression of a Ligand and Its Receptor
2005 StandoutNobel
Nucleic-acid therapeutics: basic principles and recent applications
2002
Angiogenesis Ischemic and Neoplastic Disorders
2003 StandoutNobel
Cognitive Functioning and Quality of Life in Malignant Glioma Patients: A Review of the Literature
1997
The Chemistry of Neutron Capture Therapy
1998 Standout
Activatable Photosensitizers for Imaging and Therapy
2010 Standout
Disrupting insulin-like growth factor signaling as a potential cancer therapy
2007
Neurobehavioral Status and Health-Related Quality of Life in Newly Diagnosed High-Grade Glioma Patients
2001
Left ventricular hypertrophy in patients with hypertension: importance of blood pressure response to regularly recurring stress.
1983
HIF-1 and human disease: one highly involved factor
2000 StandoutNobel
Expression of hypoxia-inducible factor 1? in brain tumors
2000 StandoutNobel
Role ofVHLGene Mutation in Human Cancer
2004 StandoutNobel
Glucocorticoid-Induced TNF Receptor Family Related Gene Activation Overcomes Tolerance/Ignorance to Melanoma Differentiation Antigens and Enhances Antitumor Immunity
2006 StandoutNobel
Construction and Validation of Improved Triple Fusion Reporter Gene Vectors for Molecular Imaging of Living Subjects
2007 StandoutNobel
Works of Robert Aiken being referenced
A randomized, double-blind, placebo-controlled phase 2 trial of dendritic cell (DC) vaccination with ICT-107 in newly diagnosed glioblastoma (GBM) patients.
2014
Regression of C6 rat brain tumors by cells expressing an antisense insulin-like growth factor I receptor RNA.
1996
Results of a Pilot Study Involving the Use of an Antisense Oligodeoxynucleotide Directed Against the Insulin-Like Growth Factor Type I Receptor in Malignant Astrocytomas
2001
Metronidazole in the treatment of metastatic brain tumors
1984
Is near basal blood pressure a more accurate predictor of cardiorenal manifestations of hypertension than casual blood pressure?
1978
Quality-of-life issues in patients with malignant gliomas.
1994